You are here

Development of rat liver 3D organoid methods to address genotoxicity screening

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43ES032345-01
Agency Tracking Number: R43ES032345
Amount: $176,622.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: R
Solicitation Number: ES20-005
Solicitation Year: 2019
Award Year: 2020
Award Start Date (Proposal Award Date): 2020-09-25
Award End Date (Contract End Date): 2021-08-31
Small Business Information
Rochester, NY 14623-2860
United States
DUNS: 085992055
HUBZone Owned: No
Woman Owned: Yes
Socially and Economically Disadvantaged: No
Principal Investigator
 (585) 442-0930
Business Contact
Phone: (585) 442-0930
Research Institution

Project Summary
Studying cells in simple 2D culture systems has many advantages with of ease of use,
ability to screen many conditions in a short amount of time, targeted addition or deletion
of genes, proteins or other components and focused study of specific pathways
representing only a few. However, that simplicity can also lead to loss of key functions
and an overall lack of relevancy to whole organisms, especially humans. In an effort to
bridge this gap between cells in a dish and a human being, in vitro models are being
developed that mimic the function of whole organs, so-called organotypic cultures.
These models represent an opportunity to study highly complex, multicellular systems
that will respond more like actual organs as opposed to cells grown in a simple
monolayer. Our studies will develop a model of rat liver cells grown in a 3-dimensional
format and pair that with an efficient, high-content analytical platform that will provide
information on DNA function and cell health. The value of these types of models is
significant for both basic science and more targeted research efforts such as human
safety studies. Assessment of the safety of compounds like drug candidates, industrial
chemicals and consumer products relies on preclinical test models to report useful
information of human safety. The ability of cell-based models to do this is often
challenged when the in vitro and in vivo systems lack sufficient relevancy to the human
condition. The proposed 3D organ models may overcome existing limitations and result
in lower costs while providing better information. The combination of data-rich assays
that enable fast and efficient assessment of in vitro animal-derived organ models
represents an opportunity to improve safety testing and create tools that will benefit
numerous other research initiatives that rely on in vitro systems.Project Narrative
Recent advances in cell culture have lead to the development of highly complex
miniaturized tissue systems that replicate the function of human organs.
The use of more relevant animal-derived organ models and the development of tools to
better assess their responses could greatly improve chemical/drug safety studies, as
well as aid in discoveries made in the basic sciences. This project seeks to create novel
assays that can be used to provide quantitative information on activity and toxicological
responses of complex 3D liver models to improve the relevancy and efficacy of these
important in vitro organ systems.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government